Skip to content
  • Sunday, 26 July 2026
  • 2:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The Aging Atlas: Unlocking the Secrets of Cellular Decline Across Mammalian Tissues
Molecular & Cell Biology

The Aging Atlas: Unlocking the Secrets of Cellular Decline Across Mammalian Tissues

Angie Faith Apr 8, 2026 0

Growing older is an inevitable biological process, one that is increasingly understood to be a significant risk factor for a…

Read More
Molecular & Cell Biology

Oxford Researchers Engineer Breakthrough Supplement to Combat Alarming Honeybee Decline

Angie Faith Apr 3, 2026 0

A groundbreaking advancement in bee nutrition has emerged from a collaborative effort led by the University of Oxford, potentially offering…

Read More
Molecular & Cell Biology

A Breakthrough Food Supplement Could Reverse Alarming Decline of Honeybees

Angie Faith Mar 27, 2026 0

A groundbreaking food supplement, developed by a collaborative team of researchers led by the University of Oxford, promises to offer…

Read More
Neuroscience & Brain Research

Long-Term Harvard Study Identifies Link Between Caffeinated Coffee and Tea Consumption and Reduced Risk of Dementia and Cognitive Decline

Rifan Muazin Mar 26, 2026 0

In a landmark investigation spanning four decades, researchers from Mass General Brigham, the Harvard T.H. Chan School of Public Health,…

Read More
Neuroscience & Brain Research

Cerebrovascular Function and Oxygen Regulation as Early Biomarkers for Alzheimer’s Disease Risk and Cognitive Decline

Rifan Muazin Mar 24, 2026 0

The intricate relationship between the brain’s vascular health and the onset of neurodegenerative conditions has reached a new milestone with…

Read More
Neuroscience & Brain Research

Moderate Consumption of Caffeinated Coffee and Tea Associated with Reduced Risk of Dementia and Slower Cognitive Decline Over Four Decades

Rifan Muazin Mar 18, 2026 0

In a comprehensive longitudinal analysis that spans more than 40 years of clinical observation, researchers from Mass General Brigham, the…

Read More

Posts pagination

1 … 4 5
TWiV 1291: A Foot in the Door for CytomegalovirusResearchers Uncover Glioblastoma’s Systemic Impact on the Skull and Immune System Challenging Current Treatment ParadigmsDNA Aptamers Offer Breakthrough in Identifying Senescent Cells, Paving the Way for New Aging and Disease TreatmentsIndiana University Scientists Develop Breakthrough Multiplex Imaging Technique to Map Bone Marrow Microenvironments
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ